Novozymes A/S
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
4.644.193.913.72
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$14.11$15.62$16.73$17.56

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
32.0135.5124.0233.4226.2329.4034.5048.0026.3734.0753.9626.23
Price/Sales ratio
6.497.165.187.175.886.456.9510.105.525.758.315.88
Price/Book Value ratio
7.178.656.249.267.408.088.6712.767.007.371.388.08
Price/Cash Flow ratio
17.8730.0219.0825.6523.0029.0122.3837.1724.2024.8117.1329.01
Price/Free Cash Flow ratio
21.2743.4327.9243.9637.0042.1728.5453.5186.8749.1641.4137.00
Price/Earnings Growth ratio
2.052.542.418.275.03-65.33-3.853.861.51-1.870.13-65.33
Dividend Yield
0.97%0.92%1.44%1.14%1.55%1.55%1.52%0.97%1.57%2.77%1.02%1.55%
Profitability Indicator Ratios
Gross Profit Margin
57.38%58.05%57.46%57.89%57.36%55.33%56.04%57.67%54.56%54.31%46.66%55.33%
Operating Profit Margin
27.16%27.73%27.90%27.85%28.28%28.09%26.06%26.80%26.37%22.21%15.66%28.09%
Pretax Profit Margin
26.31%25.86%27.44%26.67%27.35%26.42%25.12%26.24%25.95%21.83%12.06%26.42%
Net Profit Margin
20.27%20.16%21.56%21.46%22.41%21.94%20.16%21.04%20.94%16.89%9.28%21.94%
Effective Tax Rate
22.99%21.98%21.41%19.50%18.01%16.95%19.73%19.85%19.09%22.25%23.39%18.01%
Return on Assets
13.70%15.86%16.34%16.97%16.37%15.43%13.77%12.70%13.13%10.65%1.85%15.43%
Return On Equity
22.41%24.37%25.99%27.71%28.23%27.50%25.14%26.60%26.56%21.63%4.38%27.50%
Return on Capital Employed
23.36%26.80%26.13%29.33%28.71%25.72%22.33%20.98%22.02%18.81%3.50%25.72%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.10N/A
Quick Ratio
1.301.171.090.770.720.931.090.850.780.800.680.93
Cash ratio
0.640.250.220.130.130.150.280.160.140.150.150.13
Days of Sales Outstanding
65.7466.6869.1664.1573.1778.8966.5572.9474.9676.9183.9473.17
Days of Inventory outstanding
150.12141.76150.95154.28167.77148.55139.91172.57174.03161.89154.44148.55
Operating Cycle
215.86208.44220.12218.43240.95227.45206.47245.52248.99238.81238.38227.45
Days of Payables Outstanding
77.1273.8972.4480.0084.3663.5065.1885.9485.5272.1377.6963.50
Cash Conversion Cycle
138.74134.54147.67138.42156.58163.94141.28159.58163.46166.68160.69156.58
Debt Ratios
Debt Ratio
0.090.070.090.120.160.190.210.070.230.250.130.19
Debt Equity Ratio
0.150.110.150.200.280.350.380.160.470.520.180.35
Long-term Debt to Capitalization
0.090.090.120.100.110.190.22N/A0.200.230.080.19
Total Debt to Capitalization
0.130.090.130.160.220.260.270.140.320.340.150.26
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A29.66N/A
Cash Flow to Debt Ratio
2.512.612.121.781.120.781.002.050.610.560.440.78
Company Equity Multiplier
1.631.531.591.631.721.781.822.092.022.031.381.78
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.360.230.270.270.250.220.310.270.220.230.290.25
Free Cash Flow / Operating Cash Flow Ratio
0.840.690.680.580.620.680.780.690.270.500.680.62
Cash Flow Coverage Ratio
2.512.612.121.781.120.781.002.050.610.560.440.78
Short Term Coverage Ratio
7.6145.1243.144.182.052.313.932.051.371.360.972.31
Dividend Payout Ratio
31.15%32.76%34.78%38.21%40.79%45.62%52.46%46.56%41.45%94.44%100.71%40.79%